Lexicon Pharmaceuticals(LXRX) - 2026 Q3 - Quarterly Report
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF (State or Other Jurisdiction of Incorporation or Organization) Delaware 76-0474169 (I.R.S. Employer Identification Number) 2445 Technology Forest Blvd. 11th Floor The Woodlands, Texas 77381 ...